Tenet receives $32 price target — 3 facts

Analysts gave Dallas-based Tenet Healthcare a $32 price target, according to Realist Investor.

Advertisement

Here are three facts:

1. Based on 11 stock opinions, Tenet’s rating score is currently 1.93.

2. For the fiscal year 2016, Tenet has estimated earnings per share of $1.59.

3. In other news, Tenet added two independent directors to its board of directors: John P. Byrnes and Peter M. Wilver.

More articles on surgery centers:
12 new ASCs in October 2016
3 recent ASC acquisitions — November 4, 2016
How physicians and hospitals can benefit from joint ventures

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • The number of ASCs per 100,000 Medicare beneficiaries varied widely across states and geographies in 2024, according to a MedPAC…

  • Investments in outpatient ventures are expanding ASCs become more integral to hospital and health systems’ throughput and financial growth—with some…

Advertisement

Comments are closed.